CClinicalTrials.gg
Not yet recruitingNCT07596056IMPULSIONUpdated May 19, 2026

Long-Term Engagement and Motivation Through Innovative Strategies in Adapted Physical Activity

An interventional study of Group A autonomy arm and classical practice and GROUP B autonomy arm and TEMPA practice in Aging, Healthy and Aging, sponsored by Centre Hospitalier Universitaire de Nice. Not yet recruiting at 1 site in France. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-19.

Sponsored by Centre Hospitalier Universitaire de Nice · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
600
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Aging is associated with progressive declines in physical, functional, and psychosocial capacities, leading to reduced autonomy, increased risk of falls, chronic diseases, and decreased quality of life. Physical inactivity is a major aggravating factor, despite strong evidence that regular physical activity helps prevent age-related decline.

Adapted Physical Activity (APA) has demonstrated beneficial effects on physical function, mental health, pain, and healthcare utilization. However, long-term adherence to APA programs among older adults remains low, with fewer than 20% meeting World Health Organization recommendations. Therefore, innovative strategies are needed to improve sustained engagement in physical activity.

This multicenter, randomized, single-blind interventional study aims to compare the effectiveness of different APA strategies on long-term engagement in physical activity among adults aged 60 years and older.

A total of 600 participants will be randomized into four groups combining two key factors: (1) autonomy-based vs. non-autonomy-based approaches, and (2) classical APA vs. TEMPA-based APA programs. Each intervention consists of a 12-week program including 24 supervised sessions, with some groups incorporating a progressive transition toward autonomous practice.

The primary outcome is long-term physical activity engagement assessed using the QAPPA questionnaire at baseline, 6 months, and 12 months.

Secondary outcomes include:

Objective and self-reported physical activity levels (questionnaires and wearable devices) Functional capacities (muscle strength, endurance, gait speed, balance, cardiorespiratory fitness) Motivational and perceptual factors (e.g., enjoyment, fatigue, perceived effort, motivation) Quality of life (EQ-5D-5L) Biological markers (inflammatory, metabolic, metabolomic, and epigenetic profiles) to identify predictors of adherence and physiological response Cost-effectiveness and cost-utility analyses (incremental cost-effectiveness ratio)

Statistical analyses will be conducted using mixed linear models for repeated measures to evaluate time, group, and interaction effects. Additional analyses will include descriptive statistics, group comparisons, longitudinal trends, and economic evaluations.

This study aims to identify effective and sustainable APA strategies to improve long-term physical activity engagement and inform public health policies for older adults.

02

Conditions studied

  • Aging, Healthy
  • Aging

Keywords

  • Adapted Physical Activity
  • aging
03

In context

Lead sponsor

Centre Hospitalier Universitaire de Nice is the lead sponsor of 709 studies on the registry; 176 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age 60 or older
  • Affiliation with, or beneficiary of, a social security system
  • No objection to the study

Exclusion criteria

Exclusion Criteria:

  • Neurocognitive disorder preventing the provision of informed consent (MOCA \<18)
  • Individuals under legal protection
  • Individuals deprived of liberty
  • Presence of a physical or cognitive condition preventing participation in the adapted physical activity protocol over 3 months:
  • Neurocognitive disorder (MOCA \<18)
  • Neurodegenerative disease with severe symptoms preventing participation in the protocol
  • Neuromuscular disease with severe symptoms preventing participation in the protocol
  • Severe sensory impairments (blindness or profound deafness)
  • Amputation of one or more limbs
  • Non-independent mobility
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
600 participants (estimated)

Study arms

  • Experimental
    group A

    autonomy arm and classical practice

    Other: Group A autonomy arm and classical practice

  • Experimental
    group B

    autonomy arm and TEMPA practice

    Other: GROUP B autonomy arm and TEMPA practice

  • Experimental
    group C

    non-autonomy arm and classical practice

    Other: Group C non-autonomy arm and classical practice

  • Experimental
    group D

    non-autonomy arm and TEMPA practice

    Other: Group D non-autonomy arm and TEMPA practice

Interventions

  • OtherGroup A autonomy arm and classical practice

    All participants in Group A will receive a total of 24 Adapted Physical Activity (APA) sessions delivered by a qualified APA professional over a 15-week period. Two sessions per week will be provided during the first 9 weeks. From week 10 to week 15, only one supervised in-person session per week will be offered, and participants will be asked to complete the second session independently. This transition in session planning is expected to promote more sustainable long-term engagement in physical activity, Each session will consist of a warm-up (approximately 10-15 minutes), a main exercise phase (including endurance, strength, balance, flexibility, and coordination exercises), and a cool-down period. The structure of the sessions will be consistent and will comply with physical activity prescription guidelines for older adults

  • OtherGROUP B autonomy arm and TEMPA practice

    In Group B, sessions will more explicitly incorporate effort minimization strategies (TEMPA), which will be clearly communicated to participants. These strategies include encouraging focus on perceived enjoyment during exercise, allowing participants to choose music, involving participants in leading warm-ups, integrating game-based activities (e.g., dodgeball-type games), strengthening group cohesion and sense of affiliation, and providing individualized feedback on performance during sessions. To ensure proper implementation, the instructor will receive specific training in the TEMPA theoretical model and its associated adaptations. The instructor will also be required to explicitly communicate the strategies used during sessions. A report documenting the strategies implemented will be completed by the instructor after each session

  • OtherGroup C non-autonomy arm and classical practice

    All participants in Group C will receive a total of 24 Adapted Physical Activity (APA) sessions delivered by a qualified APA professional over a 12-week period. Participants will attend two APA sessions per week.

  • OtherGroup D non-autonomy arm and TEMPA practice

    In Group D, sessions will more explicitly incorporate effort minimization strategies (TEMPA), which will be clearly communicated to participants. These strategies include encouraging participants to focus on perceived enjoyment during exercise, allowing them to choose music, involving them in leading the warm-up, integrating game-based activities (e.g., dodgeball-type games), strengthening group cohesion and sense of affiliation, and providing individualized feedback on performance during sessions.

06

What researchers measure

Primary outcomes

  1. effectiveness of different Adapted Physical Activity (APA) programs

    The primary objective of this study is to compare the effectiveness of different Adapted Physical Activity (APA) programs on long-term engagement in physical activity among older adults. Long-term engagement will be assessed through the level of physical activity, measured using the QAPPA questionnaire The Physical Activity Questionnaire for Older Adults (QAPPA) is a tool for measuring the physical activity of people aged 60 and over. It was developed to meet the objective of assessing the level of physical activity of older adults, taking into account their age and health.

    Time frame: at 12 months

Secondary outcomes

  1. Analyze functional outcomes: strength

    Strength: time to complete the Five Sit-to-Stand test

    Time frame: at 3 months, and 6 months and 12 months

  2. perceptual and motivational factors of engagement

    EMAPS questionnaires: The Motivation Scale for Physical Activity for Health Purposes (EMAPS) is a tool that assesses individuals' motivations and engagement in physical activity. It measures intrinsic and extrinsic motivation, based on 7 main constructs: achievement, knowledge and stimulation, external, introjected and identified regulations, and amotivation. The scale includes 28 statements, each measured on a 1 to 7-point scale, thus allowing a precise assessment of participants' motivations.

    Time frame: at base line and at 3 months

  3. perceptual and motivational factors of engagement

    PES questionnaire: The Physical Effort Scale (PES) is a tool designed to measure the approach and avoidance tendencies towards physical effort. It is used to understand the engagement in physical activity. The scale consists of two factors: approach and avoidance, with each factor having a high internal consistency. The PES-FR has been shown to be valid for measuring individual differences in physical effort evaluation and has implications for promoting physical activity.

    Time frame: at base line and at 3 months

  4. perceptual and motivational factors of engagement

    PANES questionnaire: PANES is a 17-item, self-administered questionnaire that assesses environmental factors in physical activity participation, such as neighborhood safety, aesthetic qualities, neighborhood infrastructure, and access to destinations

    Time frame: at baseline and at 3 months

  5. Analyze functional outcomes: Muscular endurance

    Muscular endurance: time to complete the One-Minute Sit-to-Stand test

    Time frame: at 3 months, and 6 months and 12 months

  6. Analyze functional outcomes: Gait analysis

    Gait analysis: walking speed over 10 meters

    Time frame: at 3 months, and 6 months and 12 months

  7. Analyze functional outcomes: Balance

    Balance: stabilometric measurements

    Time frame: at 3 months, and 6 months and 12 months

  8. Analyze functional outcomes: Body composition

    Body composition: bioelectrical impedance analysis

    Time frame: at 3 months, and 6 months and 12 months

  9. Analyze functional outcomes: Cardiorespiratory endurance

    Cardiorespiratory endurance: VO₂ max and Harvard index assessed via the Harvard Step Test

    Time frame: at 3 months, and 6 months and 12 months

07

Study locations

1 site
  • CHU de Nice - Hopital de Cimiez
    Nice, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07596056
Lead sponsor
Centre Hospitalier Universitaire de Nice
Responsible party
Sponsor
First posted
May 19, 2026
Start date
Sep 2026 (estimated)
Primary completion
Sep 2031 (estimated)
Completion
Sep 2031 (estimated)
Last update
May 19, 2026

Study contacts

FREDERIC CHORIN, PhD
Contact
chorin.f@chu-nice.fr
492034924 ext. +33
VIRGINIE PIOVANO
Contact
piovano.v@chu-nice.fr
492034194 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion